Journal of women's health
-
Journal of women's health · Apr 2013
Randomized Controlled Trial Multicenter StudyImpact of estradiol valerate/dienogest on work productivity and activities of daily living in women with heavy menstrual bleeding.
To quantify the change in work productivity and activities of daily living in North American women with heavy menstrual bleeding (HMB) treated with estradiol valerate/dienogest (E2V/DNG; Qlaira(®)/Natazia(®)) compared to placebo. ⋯ E2V/DNG was shown to have a consistent positive impact on work productivity and activities of daily living in U.S. and Canadian women with HMB. In addition, these improvements in work productivity and activities of daily living were associated with a reduction in HMB-related monetary burden compared to the placebo group.